Skip to main content

People in the News: Apr 21, 2011

Premium

Regulus Therapeutics has named Neil Gibson as its CSO.

Gibson was most recently CSO and head of oncology at Pfizer's oncology research unit. Before that, he held various positions, including CSO, at OSI Pharmaceuticals.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.